# EDGAR Filing Document

**Accession Number:** 0000778164
**File Stem:** 0001213900-25-072564
**Filing Date:** 2025-8
**Character Count:** 28043
**Document Hash:** 05836853f515f8a774ce0859e3185b30
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-072564.hdr.sgml**: 20250806

**ACCESSION NUMBER**: 0001213900-25-072564

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250806

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250806

**DATE AS OF CHANGE**: 20250806

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Alto Ingredients, Inc.
- **CENTRAL INDEX KEY:** 0000778164
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL ORGANIC CHEMICALS [2860]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 412170618
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-21467
- **FILM NUMBER:** 251189919

**BUSINESS ADDRESS:**
- **STREET 1:** 400 CAPITOL MALL, SUITE 2060
- **CITY:** SACRAMENTO
- **STATE:** CA
- **ZIP:** 95814
- **BUSINESS PHONE:** 916-403-2123

**MAIL ADDRESS:**
- **STREET 1:** 400 CAPITOL MALL, SUITE 2060
- **CITY:** SACRAMENTO
- **STATE:** CA
- **ZIP:** 95814

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Pacific Ethanol, Inc.
- **DATE OF NAME CHANGE:** 20050324

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ACCESSITY CORP
- **DATE OF NAME CHANGE:** 20030627

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DRIVERSSHIELD COM CORP
- **DATE OF NAME CHANGE:** 20001115

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **<u>August 6, 2025</u>**

**ALTO INGREDIENTS, INC.**

(Exact Name of Registrant as Specified in Charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **000-21467** | **41-2170618** |
| (State or Other Jurisdiction | (Commission File Number) | (IRS Employer |
| of Incorporation) |  | Identification No.) |

---

---

| | |
|:---|:---|
| **1300 South Second Street<br> Pekin, Illinois** | **61554** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

Registrant's Telephone Number, Including Area Code: **<u>(833) 710-2586</u>**

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.001 par value | ALTO | The Nasdaq Stock Market LLC <br>(Nasdaq Capital Market) |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02. Results of Operations and Financial Condition.**

On August 6, 2025, Alto Ingredients, Inc. issued a press release announcing certain results of operations for the three and six months ended June 30, 2025. A copy of the press release is furnished (not filed) as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in this Item 2.02 of this Current Report on Form 8-K is not incorporated by reference into any filings of Alto Ingredients, Inc. made under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in the filing unless specifically stated so therein.

**Item 9.01. Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Exhibits</u>.

<u>Number</u> <u>Description</u> <br> 99.1 [Press Release dated August 6, 2025](ea025198401ex99-1_altoingred.htm) <br> 104 Cover Page Interactive Data File (formatted as Inline XBRL)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: August 6, 2025 | ALTO INGREDIENTS, INC. | ALTO INGREDIENTS, INC. |
|  | By: | /S/ AUSTE M. GRAHAM |
|  |  | Auste M. Graham, |
|  |  | Chief Legal Officer and Secretary |

---

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

**Alto Ingredients, Inc. Reports Second Quarter 2025 Results**

***- Western Assets Increased Gross Profit by $5.6 Million, Compared to Q2 2024 -***

**Pekin, IL, August 6, 2025 – Alto Ingredients, Inc. (NASDAQ: ALTO)**, a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, reported its financial results for the quarter ended June 30, 2025.

"In 2025, our higher productivity and efficiency initiatives positively impacted our financial position. These successes reflect our commitment to projects with near-term returns and long-term benefits," said Bryon McGregor, President and Chief Executive Officer of Alto Ingredients. "In the second quarter of 2025, our Western assets generated gross profit, reflecting the positive impact of our liquid CO<sub>2</sub> facility acquisition and our decision to cold-idle our Magic Valley facility due to adverse market factors. Our marketing and distribution segment improved because we integrated our bulk sales customers, continued third-party ethanol marketing relationships that met profitability criteria, and transitioned away from business that had limited returns. We partially offset the negative impact of the previously announced loading dock outage at Pekin by capitalizing on our operational flexibility, selling higher-margin ISCC export products into Europe, and rightsizing corporate overhead to align with our current company footprint. In the second quarter of 2025, this corporate reorganization exceeded our annualized savings goal of approximately $8 million.

"Several positive regulatory developments, including the 45Z credit extension through the end of 2029, are beneficial for the industry. This has improved our earnings profile, increasing the intrinsic valuation of our facilities and creating opportunities for at least two of our plants to apply for credits for up to nearly $18 million in the next two years based on our nameplate and targeted carbon intensity scores. To execute our short-term payback strategy, we are evaluating projects to lower our carbon intensity, to capture more of the benefits from favorable regulations, improve prospects to monetize our Western assets, and increased our CO<sub>2</sub> utilization at our Pekin campus and at Columbia. We expect that this approach will support our path to profitability."

**Financial Results for the Three Months Ended June 30, 2025 Compared to 2024** 

● Net sales were $218.4 million, compared to $236.5 million.

● Cost of goods sold was $220.4 million, compared to $228.9 million.

● Gross loss was $1.9 million, compared to gross profit of $7.6 million. The year-over-year change in unrealized noncash derivatives was negative $13.2 million and the realized derivatives gain was positive $7.6 million, resulting in a net unfavorable change of $5.6 million. Although the market crush continued to improve in 2025, it was still on average $0.10 lower than in the second quarter of 2024.

![](ex99-1_001.jpg)

● Selling, general and administrative expenses were $6.2 million, compared to $9.0 million.

● Interest expense was $2.8 million, compared to $1.7 million.

● Net loss attributable to common stockholders was $11.3 million, or $0.15 per share, compared to $3.4 million, or $0.05 per share.

● Adjusted EBITDA was negative $0.2 million, including $4.7 million in realized gains on derivatives, compared to negative $5.9 million, including $2.9 million in realized losses on derivatives.

**Financial Results for the Six Months Ended June 30, 2025 Compared to 2024** 

● Net sales were $445.0 million, compared to $477.1 million.

● Cost of goods sold was $448.7 million, compared to $471.9 million.

● Gross loss was $3.7 million, compared to a gross profit of $5.2 million. The year-over-year change in unrealized noncash derivatives was negative $14.8 million and the realized derivatives gain was positive $7.6 million, resulting in a net unfavorable impact of $7.2 million. Although the market crush continued to improve in 2025, it was still on average lower than in the first half of 2024.

● Selling, general and administrative expenses were $13.4 million, compared to $16.9 million.

● Interest expense was $5.5 million, compared to $3.3 million.

● Net loss attributable to common stockholders was $23.3 million, or $0.31 per share, compared to $15.5 million, or $0.21 per share.

● Adjusted EBITDA was negative $4.6 million, including $4.9 million in realized gains on derivatives, compared to negative $13.0 million, including $2.7 million in realized losses on derivatives.

![](ex99-1_001.jpg)

Cash and cash equivalents at June 30, 2025 were $29.8 million, compared to $26.8 million at March 31, 2025 and $35.5 million at December 31, 2024. At June 30, 2025, the company's borrowing availability was $70 million including $5 million under the company's operating line of credit and $65 million under its term loan facility, subject to certain conditions.

**Second Quarter 2025 Results Conference Call**

Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Wednesday, August 6, 2025, and will deliver prepared remarks via webcast followed by a question-and-answer session.

The webcast for the conference call can be accessed from Alto Ingredients' website at www.altoingredients.com. Alternatively, to receive a number and unique PIN by email, register here. To dial directly up to twenty minutes prior to the scheduled call time, please dial (833) 630-0017 domestically and (412) 317-1806 internationally. The webcast will be archived for replay on the Alto Ingredients website for one year. In addition, a telephonic replay will be available at 8:00 p.m. Eastern Time on Wednesday, August 13, 2025. To access the replay, please dial (877) 344-7529. International callers should dial 00-1 412-317-0088. The pass code will be 1666529.

**Use of Non-GAAP Measures**

Management believes that certain financial measures not in accordance with generally accepted accounting principles ("GAAP") are useful measures of operations. The company defines Adjusted EBITDA as unaudited consolidated net income (loss) before interest expense, interest income, provision for income taxes, asset impairments, unrealized derivative gains and losses, acquisition-related expense and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss). Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company's performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool, and you should not consider this measure in isolation or as a substitute for analysis of the company's results as reported under GAAP.

**About Alto Ingredients, Inc.**

Alto Ingredients, Inc. (NASDAQ: ALTO) is a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients. Leveraging the unique qualities of its facilities, the company serves customers in a wide range of consumer and commercial products in the Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. For more information, please visit www.altoingredients.com.

![](ex99-1_001.jpg)

**<u>Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995</u>**

Statements and information contained in this communication that refer to or include Alto Ingredients' estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients' current perspective of existing trends and information as of the date of the communication. Forward-looking statements generally will be accompanied by words such as "anticipate," "believe," "plan," "could," "should," "estimate," "expect," "forecast," "outlook," "guidance," "intend," "may," "might," "will," "possible," "potential," "predict," "project," or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning Alto Ingredients' projected outlook and future performance, including the anticipated timing and effects of its productivity and efficiency initiatives; expectations around, and the anticipated timing and effects of, regulatory developments, including the Section 45Z credit extension and the dollar amounts of credits for which Alto Ingredients may be eligible to apply and receive; and Alto Ingredients' other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients' plans, objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients' current expectations depending upon a number of factors affecting Alto Ingredients' business and plans. These factors include, among others adverse economic and market conditions, including for renewable fuels, specialty alcohols and essential ingredients; export conditions and international demand for the company's products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; adverse impacts of inflation and supply chain constraints, including from tariffs; Alto Ingredients' ability to timely and fully realize the results of its productivity and cost saving initiatives; regulatory developments and Alto Ingredients' ability to successfully pursue and secure opportunities, and realize the expected results, under existing and new legislation, including the Section 45Z regulations, and to successfully apply for and receive anticipated credit amounts. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients' products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the alcohol production, marketing and distribution industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients' facilities, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients' filings with the Securities and Exchange Commission including, specifically, those factors set forth in the "Risk Factors" section contained in Alto Ingredients' Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2025.

**Company IR and Media Contact:** 

Michael Kramer, Alto Ingredients, Inc., 916-403-2755

Investorrelations@altoingredients.com

**IR Agency Contact:** 

Kirsten Chapman, Alliance Advisors Investor Relations, 415-433-3777

altoinvestor@allianceadvisors.com

![](ex99-1_001.jpg)

**ALTO INGREDIENTS, INC.<br> CONSOLIDATED STATEMENTS OF OPERATIONS**

**(unaudited, in thousands, except per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended <br>June 30, | Three Months Ended <br>June 30, | Six Months Ended <br>June 30, | Six Months Ended <br>June 30, |
|  | 2025 | 2024 | 2025 | 2024 |
| Net sales | $218436 | $236468 | $444976 | $477097 |
| Cost of goods sold | 220373 | 228915 | 448720 | 471944 |
| Gross profit (loss) | (1937) | 7553 | (3744) | 5153 |
| Selling, general and administrative expenses | 6171 | 8961 | 13361 | 16893 |
| Loss from operations | (8108) | (1408) | (17105) | (11740) |
| Interest expense, net | (2811) | (1669) | (5540) | (3303) |
| Other income (expense), net | (78) | (29) | (31) | 212 |
| Loss before provision for income taxes | (10997) | (3106) | (22676) | (14831) |
| Provision for income taxes |  |  |  |  |
| Net loss | $(10997) | $(3106) | $(22676) | $(14831) |
| Preferred stock dividends | $(315) | $(316) | $(627) | $(631) |
| Net loss attributable to common stockholders | $(11312) | $(3422) | $(23303) | $(15462) |
| Net loss per share, basic and diluted | $(0.15) | $(0.05) | $(0.31) | $(0.21) |
| Weighted-average shares outstanding, basic and diluted | 74611 | 73486 | 74232 | 73126 |

---

**ALTO INGREDIENTS, INC.<br> CONSOLIDATED BALANCE SHEETS<br> (unaudited, in thousands, except par value)**

---

| | | |
|:---|:---|:---|
|  | June 30, <br> 2025 | December 31,<br> 2024 |
| **<u>ASSETS</u>** |  |  |
| **Current Assets:** |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $29768 | $35469 |
| &nbsp;&nbsp;&nbsp;Restricted cash | 723 | 742 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 57454 | 58217 |
| &nbsp;&nbsp;&nbsp;Inventories | 53867 | 49914 |
| &nbsp;&nbsp;&nbsp;Derivative instruments | 2563 | 3313 |
| &nbsp;&nbsp;&nbsp;Other current assets | 5350 | 5463 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 149725 | 153118 |
| Property and equipment, net | 207997 | 214742 |
| **Other Assets:** |  |  |
| &nbsp;&nbsp;&nbsp;Right of use operating lease assets, net | 19255 | 20553 |
| &nbsp;&nbsp;&nbsp;Intangible assets, net | 7885 | 4509 |
| &nbsp;&nbsp;&nbsp;Other assets | 8203 | 8516 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other assets | 35343 | 33578 |
| **Total Assets** | $393065 | $401438 |

---

**ALTO INGREDIENTS, INC.<br> CONSOLIDATED BALANCE SHEETS (CONTINUED)<br> (unaudited, in thousands, except par value)**

---

| | | |
|:---|:---|:---|
|  | June 30,<br> 2025 | December 31,<br> 2024 |
| **<u>LIABILITIES AND STOCKHOLDERS' EQUITY</u>** |  |  |
| **Current Liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $15705 | $20369 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities | 16021 | 24214 |
| &nbsp;&nbsp;&nbsp;Current portion – operating leases | 4984 | 4851 |
| &nbsp;&nbsp;&nbsp;Derivative instruments | 910 | 1177 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 4893 | 7193 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 42513 | 57804 |
| Long-term debt, net | 118323 | 92904 |
| Operating leases, net of current portion | 15414 | 16913 |
| Other liabilities | 8970 | 8754 |
| **Total Liabilities** | 185220 | 176375 |
| **Stockholders' Equity:** |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, $0.001 par value; 10,000 shares authorized; <br> Series A: no shares issued and outstanding as of <br> June 30, 2025 and December 31, 2024 <br> Series B: 927 shares issued and outstanding as of <br> June 30, 2025 and December 31, 2024 | 1 | 1 |
| &nbsp;&nbsp;&nbsp;Common stock, $0.001 par value; 300,000 shares authorized; 77,201 and 76,565 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 77 | 77 |
| &nbsp;&nbsp;&nbsp;Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of June 30, 2025 and December 31, 2024 |  |  |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 1050261 | 1044176 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 4975 | 4975 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (847469) | (824166) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Stockholders' Equity | 207845 | 225063 |
| **Total Liabilities and Stockholders' Equity** | $393065 | $401438 |

---

![](ex99-1_001.jpg)

**<u>Reconciliation of Adjusted EBITDA to Net Loss</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended <br>June 30, | Three Months Ended <br>June 30, | Six Months Ended <br>June 30, | Six Months Ended <br>June 30, |
| *(in thousands) (unaudited)* | 2025 | 2024 | 2025 | 2024 |
| Net loss | $(10997) | $(3106) | $(22676) | $(14831) |
| Adjustments: |  |  |  |  |
| Interest expense | 2811 | 1669 | 5540 | 3303 |
| Interest income | (67) | (150) | (150) | (325) |
| Unrealized derivative losses (gains) | 2117 | (11089) | 483 | (14279) |
| Acquisition-related (income) expense | (460) | 675 | (460) | 1350 |
| Depreciation and amortization expense | 6365 | 6074 | 12631 | 11802 |
| &nbsp;&nbsp;&nbsp;Total adjustments | 10766 | (2821) | 18044 | 1851 |
| Adjusted EBITDA | $(231) | $(5927) | $(4632) | $(12980) |

---

**<u>Sales and Operating Metrics (unaudited)</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended <br>June 30, | Three Months Ended <br>June 30, | Six Months Ended <br>June 30, | Six Months Ended <br>June 30, |
|  | 2025 | 2024 | 2025 | 2024 |
| *Alcohol Sales (gallons in millions)* |  |  |  |  |
| Pekin Campus renewable fuel gallons sold | 28.8 | 30.7 | 61.4 | 62.5 |
| Western production renewable fuel gallons sold | 8.3 | 9.0 | 16.6 | 20.2 |
| Third-party renewable fuel gallons sold | 29.7 | 34.4 | 54.1 | 64.1 |
| Total renewable fuel gallons sold | 66.8 | 74.1 | 132.1 | 146.8 |
| Specialty alcohol gallons sold | 19.9 | 21.0 | 44.2 | 47.3 |
| Total gallons sold | 86.7 | 95.1 | 176.3 | 194.1 |
| *Sales Price per Gallon* |  |  |  |  |
| Pekin Campus production | $1.95 | $1.98 | $1.92 | $1.94 |
| Western production | $2.00 | $1.94 | $1.98 | $1.86 |
| Marketing and distribution | $1.96 | $2.04 | $1.98 | $1.94 |
| Consolidated sales price per gallon | $1.95 | $2.00 | $1.94 | $1.93 |
| *Alcohol Production (gallons in millions)* |  |  |  |  |
| Pekin Campus production | 50.9 | 50.0 | 105.2 | 103.6 |
| Western production | 8.3 | 8.6 | 16.6 | 18.3 |
| Total production gallons | 59.2 | 58.6 | 121.8 | 121.9 |
| *Corn Cost per Bushel* |  |  |  |  |
| Pekin Campus production | $4.86 | $4.50 | $4.75 | $4.62 |
| Western production | $5.71 | $5.78 | $5.83 | $5.84 |
| Consolidated cost per bushel | $4.98 | $4.68 | $4.89 | $4.81 |

---

![](ex99-1_001.jpg)

**<u>Sales and Operating Metrics (unaudited)</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> June 30, | Three Months Ended<br> June 30, | Six Months Ended<br> June 30, | Six Months Ended<br> June 30, |
|  | 2025 | 2024 | 2025 | 2024 |
| *Average Market Metrics* |  |  |  |  |
| PLATTS Ethanol price per gallon | $1.72 | $1.79 | $1.72 | $1.67 |
| CME Corn cost per bushel | $4.51 | $4.43 | $4.62 | $4.39 |
| Board corn crush per gallons (1) | $0.11 | $0.21 | $0.07 | $0.10 |
| *Essential Ingredients Sold (thousand tons)* |  |  |  |  |
| **Pekin Campus production:** |  |  |  |  |
| Distillers grains | 70.2 | 79.7 | 160.9 | 167.4 |
| CO2 | 45.1 | 43.3 | 90.4 | 82.4 |
| Corn wet feed | 28.7 | 24.8 | 63.2 | 50.4 |
| Corn dry feed | 21.4 | 19.8 | 45.2 | 38.7 |
| Corn oil and germ | 18.9 | 17.5 | 38.5 | 35.3 |
| Syrup and other | 11.7 | 11.1 | 19.9 | 20.6 |
| Corn meal | 8.3 | 8 | 17.7 | 16.3 |
| Yeast | 5.7 | 5.8 | 12.1 | 11.5 |
| Total Pekin Campus essential ingredients sold | 210 | 210 | 447.9 | 422.6 |
| **Western production:** |  |  |  |  |
| Distillers grains | 61.8 | 61.8 | 119.9 | 133.6 |
| CO2 | 14.4 | 15.1 | 27 | 28.4 |
| Syrup and other | 1.2 | 2 | 2 | 16.2 |
| Corn oil | 1 | 0.9 | 2.4 | 2.4 |
| Total Western production essential ingredients sold | 78.4 | 79.8 | 151.3 | 180.6 |
| Total Essential Ingredients Sold | 288.4 | 289.8 | 599.2 | 603.2 |
| *Essential ingredients return % (2)* |  |  |  |  |
| Pekin Campus return | 44.2% | 48.8% | 46.1% | 50.0% |
| Western production return | 50.8% | 35.1% | 49.9% | 37.4% |
| Consolidated total return | 45.2% | 45.6% | 46.7% | 47.8% |

---

(1) Assumes corn conversion of 2.80 gallons
 of alcohol per bushel of corn.

(2) Essential ingredients revenues as a percentage
 of total corn costs consumed.

**<u>Segment Financials (unaudited, in thousands)</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended <br>June 30, | Three Months Ended <br>June 30, | Six Months Ended <br>June 30, | Six Months Ended <br>June 30, |
|  | 2025 | 2024 | 2025 | 2024 |
| ***<u>Net Sales</u>*** |  |  |  |  |
| Pekin Campus production, recorded as gross: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Alcohol sales | $94155 | $100687 | $201390 | $209035 |
| &nbsp;&nbsp;&nbsp;Essential ingredient sales | 39565 | 39371 | 84183 | 86080 |
| &nbsp;&nbsp;&nbsp;Intersegment sales | 183 | 286 | 481 | 606 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Pekin Campus sales | 133903 | 140344 | 286054 | 295721 |
| Marketing and distribution: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Alcohol sales, gross | $58106 | $70157 | $107101 | $124587 |
| &nbsp;&nbsp;&nbsp;Alcohol sales, net | 80 | 64 | 142 | 98 |
| &nbsp;&nbsp;&nbsp;Intersegment sales | 2334 | 2388 | 4840 | 5140 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total marketing and distribution sales | 60520 | 72609 | 112083 | 129825 |
| Western production, recorded as gross: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Alcohol sales | $16604 | $17456 | $32798 | $37690 |
| &nbsp;&nbsp;&nbsp;Essential ingredient sales | 8250 | 5950 | 16058 | 13776 |
| &nbsp;&nbsp;&nbsp;Intersegment sales | 505 |  | 769 | (130) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Western production sales | 25359 | 23406 | 49625 | 51336 |
| Corporate and other | 1676 | 2783 | 3304 | 5831 |
| Intersegment eliminations | (3022) | (2674) | (6090) | (5616) |
| Net sales as reported | $218436 | $236468 | $444976 | $477097 |
| ***<u>Cost of goods sold:</u>*** |  |  |  |  |
| Pekin Campus production | $139748 | $130200 | $294974 | $281311 |
| Marketing and distribution | 56518 | 69437 | 104167 | 123123 |
| Western production | 23501 | 27167 | 49024 | 63683 |
| Corporate and other | 1705 | 2943 | 3386 | 5738 |
| Intersegment eliminations | (1099) | (832) | (2831) | (1911) |
| Cost of goods sold as reported | $220373 | $228915 | $448720 | $471944 |
| ***<u>Gross profit (loss):</u>*** |  |  |  |  |
| Pekin Campus production | $(5845) | $10144 | $(8920) | $14410 |
| Marketing and distribution | 4002 | 3172 | 7916 | 6702 |
| Western production | 1858 | (3761) | 601 | (12347) |
| Corporate and other | (29) | (160) | (82) | 93 |
| Intersegment eliminations | (1923) | (1842) | (3259) | (3705) |
| Gross profit (loss) as reported | $(1937) | $7553 | $(3744) | $5153 |

---

####